Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
about
Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysisNew agents for the treatment of drug-resistant Mycobacterium tuberculosisWHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysisCurrent and Future Considerations for the Treatment of Hospital-Acquired PneumoniaMap the gap: missing children with drug-resistant tuberculosisThrombocytopenia in Patients Receiving Prolonged Linezolid May be Caused by Oxidative Stress.Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literatureLinezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosisLinezolid for treatment of chronic extensively drug-resistant tuberculosis.Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.Changes in chest CT findings of pulmonary tuberculosis after linezolid treatment.Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.Drug-resistant tuberculosis: emerging treatment options.Fatal persistent methicillin-resistant Staphylococcus aureus bacteremia and vascular graft infections complicated with the formation of multiple abscesses despite aggressive medical therapy.Advances in Drug Discovery and Development for Pediatric Tuberculosis.Assessment of linezolid efficacy, safety and tolerability in the treatment of tuberculosis: A retrospective case reviewUpdate in tuberculosis and nontuberculous mycobacterial disease 2010.New treatment options for multidrug-resistant tuberculosis.Recent advances in tuberculosis and nontuberculous mycobacteria lung disease.Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.The anti-tuberculosis agents under development and the challenges ahead.Adverse effects of oral second-line antituberculosis drugs in children.An Update on Repurposed Medications for the Treatment of Drug-Resistant Tuberculosis.Filgrastim therapy in a child with neutropenia induced by linezolid.The spread of drug-resistant tuberculosis in children: an Italian case series.Treatment of Tuberculous Meningitis and Its Complications in Adults.Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report
P2860
Q26743380-5A782978-97B0-42E6-BDE8-4C6368396997Q26751463-3291C427-A18A-45DD-9B44-07DD82D638F0Q26852253-05903490-50C9-4359-87F2-1569E7BB9C6BQ28071882-A7FF3753-4391-43DF-A8F3-FF286AA2E6F0Q28547002-00BE5E0A-EA0E-406A-AFBA-39E8D1BC6C12Q33427112-35C33B3B-236A-47DE-8910-A8F3E90D29FFQ33791908-264113F7-AF20-4842-9DC7-9514F99743B7Q34299173-4F2FC4EB-DD0C-4C77-8B76-7D17BB9F4133Q34529109-0160BF3E-FE2C-4AEB-9A8C-608206AF32B9Q34644127-6FF1EC7F-38EE-4847-9C52-A1E99CB2EB04Q35026558-E4AD2F3C-8DE1-453F-99FD-5C3FD439158BQ35059096-F4A22E2F-C123-4D4C-B079-7C06565F13CAQ35568367-FD38EDC7-5AFB-4670-88E4-E2EE85CFD7C4Q35683967-C0D2A7FC-557E-41D0-982D-4E462FFB7A19Q36871505-373E3E67-0C48-4E21-BEC3-22FE58349229Q37134041-0A001922-0E6D-4071-ACF1-DBBB0BC23AC9Q37366765-7D43D46E-3CF2-4C85-BA62-E38C1B61902BQ37902000-836CB8BD-618B-4BB1-9837-08EC098D3909Q38024041-6BB37A95-3C26-4D26-B8A8-AB5438DB4FCCQ38118312-E0168A39-F44A-48B2-BD65-E4419FA73E9BQ38604890-691E86E0-BA53-4CDA-87B8-922505A18130Q38617197-100A3772-C95C-441D-B441-04474F207037Q38837774-B7F93F5E-2A53-4D88-AEF8-C6C821F28917Q38885365-EDE469FE-8577-4EAB-A80F-449EB6653794Q42127998-59F1F602-A6B7-44FA-8606-89692008EFFEQ42230437-F313FB96-7BD9-4B77-BD5C-EE09C0257E11Q52680275-61BAF4E2-4A95-4E6B-9D73-760CAD5EA906Q55547799-563CDBC5-E1B0-40BF-AC94-8088E97785D2Q58706270-2AEDC303-634F-420C-8E2C-EA74AA13D632
P2860
Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linezolid use for treatment of ...... losis, New York City, 2000-06.
@ast
Linezolid use for treatment of ...... losis, New York City, 2000-06.
@en
type
label
Linezolid use for treatment of ...... losis, New York City, 2000-06.
@ast
Linezolid use for treatment of ...... losis, New York City, 2000-06.
@en
prefLabel
Linezolid use for treatment of ...... losis, New York City, 2000-06.
@ast
Linezolid use for treatment of ...... losis, New York City, 2000-06.
@en
P2093
P356
P1476
Linezolid use for treatment of ...... losis, New York City, 2000-06.
@en
P2093
Felicia Dworkin
Holly A Anger
Saarika Sharma
Shama D Ahuja
Sonal S Munsiff
P304
P356
10.1093/JAC/DKQ017
P407
P50
P577
2010-02-11T00:00:00Z